v3.26.3
SCHEDULE OF CASH AND CASH EQUIVALENTS (Details) - USD ($)
12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Impairment Effects on Earnings Per Share [Line Items]    
Cost $ 3,147,333 $ 6,832,725
Unrealized Gain (Loss)
Fair Value 3,065,829 6,702,437
Cash and Cash Equivalents 3,147,333 6,832,725
Cash [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 81,504 130,288
Unrealized Gain (Loss)
Fair Value
Cash and Cash Equivalents 81,504 130,288
Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]    
Impairment Effects on Earnings Per Share [Line Items]    
Cost 3,065,829 6,702,437
Unrealized Gain (Loss)
Fair Value 3,065,829 6,702,437
Cash and Cash Equivalents $ 3,065,829 $ 6,702,437